Expression of CD39 by human peripheral blood CD4+CD25 + T cells denotes a regulatory memory phenotype

American Journal of Transplantation

Volumn 10, Issue 11, 2010, Pages 2410-2420

  Dwyer, K M ^a   Hanidziar, D ^b   Putheti, P ^b   Hill, P A ^a   Pommey, S ^a   McRae, J L ^a   Winterhalter, A ^a   Doherty, G ^b   Deaglio, S ^c   Koulmanda, M ^b   Gao, W ^b   Robson, S C ^b   Strom, T B ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

CD4 regulatory cells; regulatory T cells; renal allograft; renal allograft rejection

Indexed keywords

5' NUCLEOTIDASE; CD39 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE SURFACE MARKER; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT REJECTION; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD4; APYRASE; CD4-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PHENOTYPE; PYROPHOSPHATASES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 78349232055     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03291.x     Document Type: Article

References (30)

1. Deaglio S, Dwyer KM, Gao W, et al,. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257 -1265.
2. Robson SC, Kaczmarek E, Siegel JB, et al,. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997; 185: 153 -163.
3. Zimmermann H., 5-Nucleotidase: Molecular structure and functional aspects. Biochem J 1992; 285 (Pt 2): 345 -365.
4. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR,. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006; 177: 6780 -6786.
5. Zhou Q, Yan J, Putheti P, et al,. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am J Transplant 2009; 9: 2303 -2311.
6. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al,. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10: 1000 -1007.
7. Dwyer K, Deaglio S, Crikis S, et al,. Salutary roles of CD39 in transplantation. Transplant Rev 2007; 21: 54 -63.
8. Borsellino G, Kleinewietfeld M, Di Mitri D, et al,. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225 -1232.
9. Fletcher JM, Lonergan R, Costelloe L, et al,. CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009; 183: 7602 -7610.
10. Miyara M, Yoshioka Y, Kitoh A, et al,. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899 -911.
11. Moncrieffe H, Nistala K, Kamhieh Y, et al,. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 2010; 185: 134 -143.
12. Yao Z, Painter SL, Fanslow WC, et al,. Human IL-17: A novel cytokine derived from T cells. J Immunol 1995; 155: 5483 -5486.
13. Niemela J, Henttinen T, Yegutkin GG, et al,. IFN-alpha induced adenosine production on the endothelium: A mechanism mediated by CD73 (ecto-5- nucleotidase) up-regulation. J Immunol 2004; 172: 1646 -1653.
14. Liu W, Putnam AL, Xu-Yu Z, et al,. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203: 1701 -1711.
15. Voo KS, Wang YH, Santori FR, et al,. Identification of IL-17-producing FOXP3 +regulatory T cells in humans. Proc Natl Acad Sci USA 2009; 106: 4793 -4798.
16. Presser D, Sester U, Mohrbach J, Janssen M, Kohler H, Sester M,. Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens. Kidney Int 2009; 76: 557 -566.
17. Solez K, Colvin RB, Racusen LC, et al,. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753 -760.
18. Gavin MA, Rasmussen JP, Fontenot JD, et al,. Foxp3-dependent programme of regulatory T cell differentiation. Nature 2007; 445: 771 -775.
19. Csoka B, Himer L, Selmeczy Z, et al,. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J 2008; 22: 3491 -3499.
20. Bopp T, Becker C, Klein M, et al,. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007; 204: 1303 -1310.
21. Aswad F, Kawamura H, Dennert G,. High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: A role for P2X7 receptors. J Immunol 2005; 175: 3075 -3083.
22. Burnstock G,. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659 -797.
23. Atarashi K, Nishimura J, Shima T, et al,. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008; 455: 808 -812.
24. Zarek PE, Huang CT, Lutz ER, et al,. A2A receptor signaling promotes peripheral tolerance by inducing T cell anergy and the generation of adaptive regulatory T cells. Blood 2008; 111: 251 -259.
25. Clark RA, Huang SJ, Murphy GF, et al,. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med 2008; 205: 2221 -2234.
26. Alam MS, Kurtz CC, Rowlett RM, et al,. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 2009; 199: 494 -504.
27. Mandapathil M, Lang S, Gorelik E, Whiteside TL,. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 2009; 346: 55 -63.
28. Sis B, Mengel M, Haas M, et al,. Banff 09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464 -471.
29. De Serres SA, Sayegh MH, Najafian N,. Immunosuppressive drugs and Tregs: A critical evaluation! Clin J Am Soc Nephrol 2009; 4: 1661 -1669.
30. Venken K, Hellings N, Thewissen M, et al,. Compromised CD4+ CD25(high) regulatory T cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123: 79 -89.